PDK4 Decrease Neuronal Apoptosis via Inhibiting ROS-ASK1/P38 Pathway in Early Brain Injury After Subarachnoid Hemorrhage

Xuan Gao,Yong-Yue Gao,Hui-Ying Yan,Guang-Jie Liu,Yan Zhou,Tao Tao,Ting-Ting Yue,Cong Pang,Xiang-Xin Chen,Sen Gao,Ling-Yun Wu,Chun-Hua Hang,Wei Li
DOI: https://doi.org/10.1089/ars.2021.0083
2022-03-01
Antioxidants and Redox Signaling
Abstract:Aims: Metabolic disorders may play key roles in oxidative stress and neuronal apoptosis in response to early brain injury (EBI) after subarachnoid hemorrhage (SAH). Pyruvate dehydrogenase (PDH) is related to oxidative stress in EBI, and its activity obviously decreases after SAH. We discovered that only pyruvate dehydrogenase kinase 4 (PDK4) expression was obviously increased among the four PDK isozymes after SAH in preliminary experiments. Therefore, we attempted to investigate the effects and corresponding mechanisms of PDK4 on oxidative stress after SAH. Results: First, we confirmed that PDK4 overexpression promoted PDH phosphorylation, inhibited PDH activity and changed cell metabolism after SAH. An siRNA targeting PDK4, a lentiviral PDK4 overexpression vector and dichloroacetic acid (DCA) were used to regulate the expression and activity of PDK4. The siRNA decreased PDH phosphorylation, promoted reactive oxygen species (ROS) production, activated the apoptosis signal-regulating kinase 1 (ASK1)/p38 pathway and induced neuronal apoptosis. The lentivirus further attenuated PDH activity, oxidative stress and neuronal apoptosis. DCA inhibited the activity of PDK4 but increased the expression of PDK4 due to a feedback mechanism. Inactivated PDK4 did not effectively suppress PDH activity, which increased ROS production, activated the ASK1/p38 pathway and led to neuronal apoptosis. Innovation: This study provides new insights into the potential antioxidant and antiapoptotic effects of the PDK4-PDH axis on EBI after SAH. Conclusions: The early overexpression of PDK4 after SAH may attenuate neuronal apoptosis by reducing oxidative stress via the ROS/ASK1/p38 pathway. PDK4 may be a new potential therapeutic target to ameliorate EBI after SAH.
biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?